Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-01-31 7:41 pm Unchanged | 13D | Cellular Biomedicine Group Inc. CBMG | Dangdai International Group Co. Ltd | 2,270,000 11.8% | 0 (Unchanged) | View |
| 2020-01-30 09:18 am Unchanged | 13D | Cellular Biomedicine Group Inc. CBMG | Liu Tony | 1,030,640 5.3% | 0 (Unchanged) | View |
| 2020-01-30 09:17 am Unchanged | 13D | Cellular Biomedicine Group Inc. CBMG | HHLR ADVISORS LTD. | 235,214 1.2% | 0 (Unchanged) | View |
| 2019-11-18 11:55 am Unchanged | 13D | Cellular Biomedicine Group Inc. CBMG | Dangdai International Group Co. Ltd | 2,270,000 11.8% | 0 (Unchanged) | View |
| 2019-11-13 10:07 am Purchase | 13D | Cellular Biomedicine Group Inc. CBMG | Liu Tony | 1,030,640 5.3% | 1,030,640 (New Position) | View |
| 2019-11-12 08:00 am Purchase | 13D | Cellular Biomedicine Group Inc. CBMG | HHLR ADVISORS LTD. | 235,214 1.2% | 235,214 (New Position) | View |